← All companiesBBioRestorative Therapies, Inc.
BRTX - CIK 0001505497
BioRestorative Therapies, Inc. net income by year
BioRestorative Therapies, Inc. (BRTX) reported net income of -$14.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
BRTX annual net income
BRTX net income 2011-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$14.24M | -58.6% |
| FY 2024 | -$8.98M | +13.8% |
| FY 2023 | -$10.42M | +21.2% |
| FY 2022 | -$13.22M | +70.2% |
| FY 2021 | -$44.30M | -293.0% |
| FY 2020 | -$11.27M | +23.0% |
| FY 2019 | -$14.65M | -17.0% |
| FY 2018 | -$12.52M | -32.5% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does BioRestorative Therapies, Inc. make?
BioRestorative Therapies, Inc. (BRTX) reported net income of -$14.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has BioRestorative Therapies, Inc.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, BioRestorative Therapies, Inc.'s net income declined from -$4.07M to -$14.24M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.